Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEBAT: Dopaminergic Effects on BAT
NCT02428933Completed
- Sponsor
- University of Amsterdam
- Start
- Oct 2013
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of bromocriptine in obesity, sponsored by University of Amsterdam. Primary endpoint: Difference in 18F-FDG uptake before and after using bromocriptin at 2 weeks. Started Oct 2013; status: completed.
02
Drugs
bromocriptine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02428933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428933.